Stockscreener 앱 받기
0.6855
2.85%
0.019
시간 외 거래:
.68
-0.0055
-0.80%
전일 마감가:
$0.6665
열려 있는:
$0.687
하루 거래량:
224.58K
Relative Volume:
0.24
시가총액:
$47.27M
수익:
$3.67M
순이익/손실:
$-13.83M
주가수익비율:
-2.4482
EPS:
-0.28
순현금흐름:
$-10.79M
1주 성능:
+12.36%
1개월 성능:
-0.13%
6개월 성능:
-34.71%
1년 성능:
-49.60%
1일 변동 폭
$0.6652
$0.70
1주일 범위
$0.6015
$0.70
52주 변동 폭
$0.58
$1.66
Icecure Medical Ltd Stock (ICCM) Company Profile
ICCM을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
ICCM
Icecure Medical Ltd
|
0.6855 | 45.96M | 3.67M | -13.83M | -10.79M | -0.28 |
|
ABT
Abbott Laboratories
|
127.04 | 222.19B | 43.84B | 13.90B | 6.92B | 7.9725 |
|
BSX
Boston Scientific Corp
|
98.65 | 144.97B | 19.35B | 2.78B | 3.82B | 1.8696 |
|
SYK
Stryker Corp
|
367.75 | 140.12B | 24.38B | 2.94B | 4.07B | 7.6159 |
|
MDT
Medtronic Plc
|
99.77 | 128.60B | 34.76B | 4.79B | 5.21B | 3.7017 |
|
EW
Edwards Lifesciences Corp
|
84.83 | 49.82B | 5.88B | 1.34B | 799.60M | 2.3489 |
Icecure Medical Ltd 주식(ICCM)의 최신 뉴스
Why retail investors pile into IceCure Medical Ltd stockPrice-to-Earnings Ratio Insights & Superior Wealth Strategies - bollywoodhelpline.com
Bond Watch: Why IceCure Medical Ltd stock is rated strong buy2025 Trading Recap & Accurate Buy Signal Alerts - moha.gov.vn
How IceCure Medical Ltd stock performs in rate cut cyclesJuly 2025 Analyst Calls & Accurate Entry/Exit Alerts - Улправда
Is IceCure Medical Ltd stock trading at a premium valuationJuly 2025 Big Picture & Weekly Consistent Profit Watchlists - Улправда
What technical signals suggest for IceCure Medical Ltd stockJuly 2025 News Drivers & Real-Time Stock Price Movement Reports - DonanımHaber
Will IceCure Medical Ltd stock benefit from sector rotationInsider Buying & Advanced Technical Analysis Signals - Улправда
Should I hold or sell IceCure Medical Ltd stock in 2025July 2025 Institutional & Stepwise Entry and Exit Trade Signals - Улправда
IceCure Medical : Company Presentation - marketscreener.com
What analysts say about IceCure Medical Ltd stockStock Market Trends & Free Significant Capital Appreciation - earlytimes.in
IceCure Expected to Report Record Fourth Quarter Sales in North - GuruFocus
IceCure (NASDAQ: ICCM) sees record Q4 North America sales after FDA clearance - Stock Titan
IceCure Expected to Report Record Fourth Quarter Sales in North America Driven by Recent FDA Clearance of ProSense® Cryoablation for Low-Risk Breast Cancer - Sahm
IceCure's ProSense® Cryoablation Featured in 4 Independent Breast Cancer Studies Presented at Radiological Society of America 2025 Annual Meeting - PR Newswire
Cryoablation: The Minimally Invasive Freezing Technology That's a Game-Changer for Treating Low-Risk, Early-Stage Breast Cancer - Future of Personal Health -
IceCure Medical (Nasdaq: ICCM) data show ProSense cuts AWE pain scores to 1 - Stock Titan
IceCure Receives Notice of Patent Allowance in China for a Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com
Is IceCure Medical Ltd a good long term investmentStop Loss Placement Tips & Turn Bull Runs into Life-Changing Wealth - earlytimes.in
Icecure Receives Notice of Patent Allowance in China for A Novel Cryogen Flow Control to Optimize Patient Cryoablation Outcomes - marketscreener.com
IceCure Medical (ICCM) Secures Patent Approval in China for Cryo - GuruFocus
IceCure Receives Notice of Patent Allowance in China for a Novel - GuruFocus
IceCure Medical Secures Patent in China for Cryogen Flow Control - TipRanks
Why IceCure Medical Ltd stock remains on buy listsJuly 2025 Movers & Real-Time Volume Analysis Alerts - Newser
How IceCure Medical Ltd stock benefits from global expansionJuly 2025 Analyst Calls & Free Accurate Trade Setup Notifications - Newser
ICCM SEC FilingsIcecure Medical Ltd. 10-K, 10-Q, 8-K Forms - Stock Titan
IceCure Medical schedules special shareholder meeting for January 2026 By Investing.com - Investing.com Canada
IceCure Medical schedules special shareholder meeting for January 2026 - Investing.com
IceCure Medical Announces Special General Meeting for Key Votes - TipRanks
Icecure Medical (ICCM) Stock Analysis Report | Ratings, Financials & Performance - Benzinga
IceCure's ProSense® Showcased at TME Fall Summit: "Take the Lead in Breast Cancer Care" Roundtable Highlighting Cryoablation Advances (PR Newswire) - Aktiellt
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Nav - GuruFocus
Icecure Medical Ltd (ICCM) Q3 2025 Earnings Call Highlights: Navigating Challenges and ... - Yahoo Finance
IceCure Reminds Shareholders of Upcoming Expiration of Rights Offering Subscription Period (PR Newswire) - Aktiellt
IceCure Medical Ltd (NASDAQ:ICCM) Q3 2025 Earnings Call Transcript - Insider Monkey
How IceCure Medical Ltd stock compares to market leadersJuly 2025 Spike Watch & High Return Trade Opportunity Guides - newser.com
Is IceCure Medical Ltd stock a bargain at current levels2025 Breakouts & Breakdowns & Smart Allocation Stock Tips - newser.com
IceCure Medical Reports Q3 2025 Financial Results - TipRanks
Is IceCure Medical Ltd a candidate for recovery playJuly 2025 Sentiment & Fast Gain Swing Trade Alerts - newser.com
IceCure Medical Ltd stock momentum explained2025 Year in Review & Verified Stock Trade Ideas - newser.com
Using Ichimoku Cloud for IceCure Medical Ltd technicals - newser.com
IceCure Medical’s Earnings Call Highlights Growth Potential - TipRanks
ICCM: FDA approval of ProSense drives growth prospects amid revenue decline and strong cash position - TradingView
Does IceCure Medical Ltd fit your quant trading modelJuly 2025 Selloffs & Intraday High Probability Setup Alerts - newser.com
IceCure Medical Q3 2025 Earnings Call Transcript - MarketBeat
IceCure Medical Gains FDA Approval for ProSense® in Breast Cancer Treatment - MSN
IceCure Medical Ltd Reports Earnings Results for the Nine Months Ended September 30, 2025 - marketscreener.com
IceCure Medical Ltd. (ICCM) Q3 FY2025 earnings call transcript - Yahoo Finance
ICCM: FDA approval for ProSense® sets stage for accelerated growth despite lower 2025 revenue - TradingView
Icecure Medical Ltd (ICCM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.64%
0.32%
자본화:
|
볼륨(24시간):